AIT's growth surges on strength in the Engineered Solutions unit and strategic buyouts, despite rising costs and soft MRO trends.

With EUV ramping and High NA traction building, ASML Holding targets up to 35 billion euros in 2025 sales backed by logic and memory demand.

After a long period of intense volatility, Lemonade, Inc. NYSE: LMND is back in the spotlight. The insurance technology company's stock has delivered powerful returns to shareholders, surging approximately 170% in the last 12 months and gaining nearly 40% in the past month alone.

A.I. monetization will be in focus for Adobe's after-hour earnings, according to Sam Vadas. She says the company needs to adapt with the evolving tech as competitors offer similar A.I.

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Fortrea business and prospects resulting in its stock trading at inflated prices.

Google stock has rebounded sharply, but investor caution persists due to AI disruption risks and legal headwinds impacting its core ad business. Despite AI competition and legal setbacks, Google's robust search dominance and ongoing AI investments provide near-term stability and recovery potential. Cloud and Waymo businesses offer additional upside, and even a possible breakup could unlock further value beyond the ad-driven narrative.

CHICAGO--(BUSINESS WIRE)--Exelon (Nasdaq: EXC) today announced a $50 million Customer Relief Fund to help low- and middle-income (LMI) customers struggling as energy supply costs escalate this summer. Exelon's local energy companies – Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO and Pepco – will join with trusted local nonprofits to determine customer eligibility and administer relief. Each nonprofit will receive a portion of the $50 million commitment as a one-time charitable contr.

Elon Musk's Tesla is suing one of its former engineers for allegedly stealing trade secrets related to its highly anticipated Optimus humanoid robot.

As jobless claims inch higher week over week, near-term PPI came in cooler than expected.

PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.

NOMD's low valuation, rising innovation and strong European category gains hint at a timely value opportunity.

Applied Materials bets big on DDR5 and HBM, projecting over 40% DRAM revenue growth and strong traction for Sym3 Magnum.

CB fuels growth with global middle-market expansion, strategic M&A, strong premiums, and a solid capital position despite catastrophe risk.

NBIS expands its AI Cloud with NVIDIA GB200 in Europe, deepening ties with NVIDIA and accelerating sovereign AI innovation.

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. SFM, HWM and ANET hold promise.

Hooker Furnishings Corporation (NASDAQ:HOFT ) Q1 2026 Earnings Conference Call June 12, 2025 9:00 AM ET Company Participants C. Earl Armstrong - CFO, Principal Financial & Accounting Officer, Senior VP of Finance & Corporate Secretary Jeremy R.

NEW YORK , June 12, 2025 /PRNewswire/ -- Newmark Title Services announces that the Company provided title and escrow services for the $700 million recapitalization and refinancing of a national multifamily portfolio owned by Nitya Capital. The 18-property, six-state portfolio includes a blend of Class A student housing and Class B market-rate multifamily assets in high-growth markets such as Dallas, Indianapolis, the Carolinas, Nashville, Phoenix and Las Vegas.

Key Points Forward stock splits usually indicate very strong fundamentals.

Amazon.com Inc (NASDAQ:AMZN) is taking tighter control of Whole Foods Market, ending much of the autonomy the grocery chain retained since its $13.7 billion acquisition in 2017, as part of a sweeping reorganization of its grocery operations. The move, revealed in a leaked internal memo, will see Whole Foods' corporate employees shift to Amazon's internal pay and performance management systems.

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck's Gardasil vaccine, court records show.